M G 32 (Glipizide and Metformin 2.5 mg / 500 mg)

Pill imprint M G 32 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 500 mg.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M G 32

Glipizide and metformin hydrochloride 2.5 mg / 500 mg M G 32
Glipizide and metformin hydrochloride 2.5 mg / 500 mg M G 32
Glipizide and metformin hydrochloride
Imprint:
M
G 32
Strength:
2.5 mg / 500 mg
Color:
White
Size:
15.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-3132
Inactive Ingredients:
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)